Eupraxia Pharmaceuticals (EPRX) Stock Chart & Stock Price History $3.90 +0.06 (+1.56%) As of 03:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Eupraxia Pharmaceuticals Stock Price Performance 5 Day Performance+16.31%1 Month Performance+5.62%3 Month Performance+31.40%6 Month Performance+54.62%Year-To-Date Performance+21.45%1 Year Performance+31.85% Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address EPRX Stock Chart for Thursday, April, 24, 2025 EPRX Chart by TradingView Eupraxia Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2025$3.84$3.85+0.26%$4.00$3.8129,210 shs$138.02 million04/23/2025$3.85$3.84-0.26%$3.98$3.7730,773 shs$137.66 million04/22/2025$3.48$3.85+10.63%$3.90$3.4911,116 shs$138.02 million04/21/2025$3.31$3.48+5.14%$3.49$3.3833,602 shs$124.76 million04/18/2025$3.31$3.31$3.29$3.196,851 shs$118.66 million04/17/2025$3.17$3.31+4.42%$3.29$3.196,851 shs$118.66 million04/16/2025$3.35$3.17-5.23%$3.26$3.174,368 shs$113.64 million04/15/2025$3.10$3.35+7.90%$3.36$2.966,276 shs$119.92 million04/14/2025$3.03$3.10+2.48%$3.12$2.983,846 shs$111.13 million04/11/2025$3.03$3.03-0.17%$3.05$2.972,421 shs$108.44 million Get the Latest News and Ratings for EPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/10/2025$3.02$3.03+0.50%$3.11$3.021,219 shs$108.62 million04/09/2025$2.97$3.02+1.52%$3.19$2.904,135 shs$108.09 million04/09/2025$2.97$3.02+1.52%$3.19$2.904,135 shs$108.09 million04/08/2025$2.97$2.97$3.25$2.9013,760 shs$105.87 million04/08/2025$2.97$2.97$3.25$2.9013,760 shs$105.87 million04/07/2025$2.93$2.97+1.40%$3.01$2.6810,077 shs$105.87 million04/04/2025$3.10$2.93-5.52%$3.32$2.9213,153 shs$104.41 million04/03/2025$3.27$3.10-5.20%$3.24$3.102,624 shs$110.50 million04/02/2025$3.24$3.27+1.08%$3.27$3.155,053 shs$116.56 million04/01/2025$3.28$3.24-1.22%$3.28$3.106,454 shs$115.32 million03/31/2025$3.33$3.28-1.62%$3.40$3.119,894 shs$116.74 million03/28/2025$3.38$3.33-1.51%$3.38$3.164,733 shs$118.67 million03/27/2025$3.44$3.38-1.60%$3.45$3.2512,436 shs$120.48 million03/26/2025$3.54$3.44-2.97%$3.68$3.363,683 shs$122.44 million03/25/2025$3.65$3.54-2.88%$3.68$3.5025,717 shs$126.19 million03/24/2025$3.82$3.65-4.58%$3.81$3.606,278 shs$129.93 million Related Companies Ginkgo Bioworks Stock Chart GH Research Stock Chart CorMedix Stock Chart Relay Therapeutics Stock Chart Sage Therapeutics Stock Chart Cullinan Therapeutics Stock Chart Tyra Biosciences Stock Chart Verve Therapeutics Stock Chart Akebia Therapeutics Stock Chart Maravai LifeSciences Stock Chart Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EPRX) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eupraxia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eupraxia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EPRX Stock Free EPRX Stock Alerts